Chang C C, Zhang J, Lombardi L, Neri A, Dalla-Favera R
Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
Oncogene. 1994 Mar;9(3):923-33.
The NFKB-2 gene (previously LYT-10, NF-kappa Bp100 or NF-kappa Bp97) codes for a NF-kappa B/rel related protein which is highly homologous to NFKB-1 (previously NF-kappa Bp105) within its rel, poly-glycine and ankyrin domains. The NFKB-2 gene is a candidate proto-oncogene since it is involved in lymphoma-associated chromosomal aberrations. In order to gain insight into the physiological function and role in tumorigenesis of NFKB-2, we have analysed its mechanism of expression and role in transcriptional regulation. We report that, contrary to previous studies, a single 3.2 kb mRNA species and its 100 kD (p100) primary translation product is detectable in all cell types tested. A second NFKB-2 protein, p52, corresponding to the amino-terminal half (rel domain) of NFKB-2 p100, is detectable in the same cell types and derives from the post-translational processing of p100. While p100 is constitutively localized in the cytoplasm, NF-kappa B induction by TPA treatment of Hela cells is associated with cytoplasmic/nuclear translocation of NFKB-2 p52 and its appearance within DNA-binding NF-kappa B complexes. NFKB-2 p52 differs from NFKB-1p50 in its differential affinity for kappa B sequences: by itself it binds H2/HLA-kappa B sites more efficiently than HIV/IgK-kappa B sites, while it can bind both sites efficiently when complexed with Rel-A(p65). Transient co-transfection of expression and reporter plasmids in cells devoid of endogenous NF-kappa B activity showed that p52 has no intrinsic transcriptional activation capabilities: it can stimulate Rel-A(p65)-driven transcription by formation of p65/p52 heterodimers, whereas, overexpressed, it down-regulates p65-dependent transcription by formation of inactive p52/p52 homodimers. These results indicate that the NFKB-2 gene codes for an inducible NF-kappa B transcription factor with the capability of differentially regulating NF-kappa B transcription depending on its abundance in the nucleus.
NFKB - 2基因(以前称为LYT - 10、NF - κBp100或NF - κBp97)编码一种与NF - κB/rel相关的蛋白质,该蛋白质在其rel、多聚甘氨酸和锚蛋白结构域内与NFKB - 1(以前称为NF - κBp105)高度同源。NFKB - 2基因是一种候选原癌基因,因为它与淋巴瘤相关的染色体畸变有关。为了深入了解NFKB - 2的生理功能及其在肿瘤发生中的作用,我们分析了其表达机制及其在转录调控中的作用。我们报告,与先前的研究相反,在所有测试的细胞类型中均可检测到单一的3.2 kb mRNA种类及其100 kD(p100)初级翻译产物。在相同的细胞类型中可检测到第二种NFKB - 2蛋白p52,它对应于NFKB - 2 p100的氨基末端一半(rel结构域),并且源自p100的翻译后加工。虽然p100组成性地定位于细胞质中,但用佛波酯(TPA)处理HeLa细胞诱导NF - κB时,与NFKB - 2 p52的细胞质/细胞核易位及其在DNA结合NF - κB复合物中的出现有关。NFKB - 2 p52与NFKB - 1p50对κB序列的亲和力不同:其自身与H2/HLA - κB位点结合的效率高于与HIV/IgK - κB位点结合的效率,而当与Rel - A(p65)形成复合物时,它可以有效地结合这两个位点。在缺乏内源性NF - κB活性的细胞中瞬时共转染表达质粒和报告质粒表明,p52没有内在的转录激活能力:它可以通过形成p65/p52异二聚体来刺激Rel - A(p65)驱动的转录,而在过表达时,它通过形成无活性的p52/p52同二聚体来下调p65依赖性转录。这些结果表明,NFKB - 2基因编码一种可诱导的NF - κB转录因子,其能够根据其在细胞核中的丰度差异调节NF - κB转录。